Madrigal Pharmaceuticals receives three new resmetirom patents
Go back to Madrigal Pharmaceuticals receives three new resmetirom patents| (NASDAQ: MDGL) | Delayed: 519.78 -2.18 (0.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $521.96 | 52 Week High | $18.24 | |||
| Open | $525.77 | 52 Week Low | $6.60 | |||
| Day High | $528.42 | P/E | N/A | |||
| Day Low | $516.62 | EPS | $0.00 | |||
| Volume | 90,470 | |||||

